Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Apellis Pharmaceuticals (APLS)
- 18.820
- -0.050-0.26%
Close Mar 17 16:00 ET
- 18.820
- 0.0000.00%
Post 16:50 ET
2.41BMarket Cap104.56P/E (TTM)
19.320High18.735Low1.34MVolume18.940Open18.870Prev Close25.34MTurnover1.61%Turnover Ratio104.56P/E (Static)127.83MShares30.48052wk High6.50P/B1.57BFloat Cap16.10052wk Low--Dividend TTM83.25MShs Float94.750Historical High--Div Yield TTM3.10%Range %11.450Historical Low18.885Avg Price1Lot Size
Apellis Pharmaceuticals (APLS) Key Financial Indicators
APLS Earnings per Share (EPS)
According to the latest financial report of Apellis Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.47. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
APLS Free Cash Flow (FCF)
Interested in knowing about Apellis Pharmaceuticals's free cash flow? The latest report shows it as -14.28M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
APLS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Apellis Pharmaceuticals shows that the company's current ratio is 3.14, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
APLS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Apellis Pharmaceuticals, the quick ratio is 2.58, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
APLS Return on Equity (ROE)
Want to learn more about the financial health of Apellis Pharmaceuticals? The latest ROE figure is -15.29%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
APLS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Apellis Pharmaceuticals, the total asset return on investment (ROA) is -5.53%.
Currency: USD
Quarterly
Loading...
APLS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Apellis Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 85.13%.
Currency: USD
Quarterly
Loading...
APLS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Apellis Pharmaceuticals, the net profit margin is -29.49%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. Over the weekend, the situation in the Mi
富哥搞钱
Feb 28 17:22
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.